Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

What does the Golden Compass do? If you've just started Act 2 and you're offered the Golden Compass as a helping hand to get you started, here's what you can expect from the item and why you should ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

Got an email about a Jilek v. Compass settlement? Payouts for millions in the US, including New Jersey, who used a vending machine in the last 11 years are being sent by check, PayPal, Venmo or Zelle ...

Robert Reffkin, Founder, Chairman & CEO, opened the call by highlighting the company’s record performance: "In Q4, Compass delivered record fourth quarter revenue of $1.7 billion, delivered record ...

Rogers Healy is out of the real estate game. The venture capitalist and residential real estate mogul has merged his Dallas-based brokerage, Rogers Healy and Associates Real Estate, into New ...

At Rocket Pro’s 2026 Ignite event, the leadership team announced a three-year partnership with Compass International Holdings that adds up to 80 basis points in purchase pricing for borrowers who work ...

Compass Coffee, the beleaguered D.C.-based chain, has a new owner. Elizabeth L. Gunn, a U.S. bankruptcy judge for the District of Columbia, approved the sale Thursday to London-based giant Caffè Nero, ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

COMP360 shows rapid symptom improvement in depression study COMP360 may compete with J&J's Spravato if approved Compass plans FDA meeting for rolling submission Feb 17 (Reuters) - Compass Pathways ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...